The Latest Cardiac and Vascular News
HANGZHOU, China, May 26, 2025 /PRNewswire/ — Zylox-Tonbridge Medical Technology Co., Ltd. (“Zylox-Tonbridge” or the “Company”) today announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™…
– Company engages U.S. critical care professionals with data-driven early warning solution MARLBOROUGH, Mass., May 26, 2025 /PRNewswire/ — VUNO, a global medical AI company, presented its flagship solution VUNO Med®–DeepCARS® at the 2025 National Teaching Institute & Critical Care…
ATLAS™ Sternal Repair Matrix is intended for challenging sternal fusion cases and IKON™ Allograft Surgical Matrix assists with soft tissue repair in high-risk patients MTF Biologics and Kolosis BIO Launch Two New Allografts to Advance Cardiac Surgery EDISON, N.J. & SALT LAKE CITY–(BUSINESS WIRE)–MTF Biologics, a global nonprofit organization that […]
WASHINGTON—A new expert opinion document jointly released by the Society for Cardiovascular Angiography and Interventions (SCAI) and the Society of Cardiovascular Computed Tomography (SCCT) presents a comprehensive framework for using coronary computed tomography angiography (CCTA) to guide percutaneous coronary intervention (PCI). Published in JSCAI, “Coronary Computed Tomography Angiography to Guide […]
At the EuroPCR 2025 Congress – Paris Results confirm the promise of non-invasive ultrasound therapy (NIUT) previously observed in earlier clinical studies. 91% of patients were free of major adverse cardiac events (MACE) at 30 days (achieving the primary endpoint objective MACE ≤ 25%). 85% of patients experienced an improvement or stabilization […]
PARIS–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease. The results of a new real-world study of more than 24,000 patients demonstrated […]
MINNEAPOLIS, May 22, 2025 /PRNewswire/ — Phraxis Inc., a Minneapolis-based medical device company, marks a major milestone with FDA approval of the EndoForce™ Connector for Endovascular Venous Anastomosis (EndoForce™) — a pivotal development in the evolution of dialysis access technology….
Number one doctor and pharmacist-recommended blood pressure monitor brand introduces blood pressure monitors with OMRON Intellisense™ AFib HOFFMAN ESTATES, Ill., May 21, 2025 /PRNewswire/ — Heralding an evolution of the blood pressure monitoring experience, heart health leader OMRON…
RapidAI detects 33% more MeVOs than Viz.ai, with new real-world data presented at ESOC highlighting superior accuracy and deeper clinical insights San Mateo, Calif. — May 21, 2025 // RapidAI, the gold standard and global leader in neurovascular AI-based clinical decision support and enterprise radiology solutions, today announced new study […]
TACOMA, Wash., May 21, 2025 /PRNewswire/ — Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced data from a post hoc analysis of its completed Phase 2 RESCUE clinical trial, showing that ischemic stroke…
